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International Journal of Radiation Oncology  Biology  PhysicsS870uptake distribution is flat across much of the sphere, with only a thin skin.
This flat uptake behavior does not changewithmotion up to amplitudes of 10
mm . We have also developed a matrix of correction factors to the flat
behavior for motion amplitudes and tumor volumes beyond these limits.
Conclusion: Our data demonstrate for the first time, that true heterogeneity
of NSCLC tumors can be modeled by SUVuptake which takes a Gaussian,
Woods-Saxon or double-peaked functional form depending on tumor
volume. The model we developed defines the “true” SUV distribution
within tumor free of artifacts due to motion, and tumor volume and will
therefore allow PET and potentially other metabolic studies to be optimally
integrated into treatment plans.
Author Disclosure: K. Wijesooriya: None. P. Peng: None. P.W. Read:
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Customized Vaginal Vault Brachytherapy With CT Imaging-derived
Applicator Prototyping
E.M. Wiebe, G. Thomas, L. Barbera, H. Easton, and A. Ravi; Odette
Cancer Centre, Toronto, ON, Canada
Purpose/Objective(s): Intracavitary vaginal brachytherapy is typically
delivered with a standard applicator of uniform diameter. The clinical use
of a stereolithographic mold technique to produce customized mold
shapes, and allow for optimized brachytherapy dose distribution, is
explored.
Materials/Methods: Stereolithographic technique is possible for cases
such as a patient with surgical pathology diagnosis of early endometrial
cancer with risk factors for local recurrence was identified clinically to
have an irregular vaginal vault configuration with deep ‘dog-ear’ config-
uration and a wide vaginal apex (4.0 cm) relative to the 2.5 cm vaginal
introitus. CT simulation images were obtained with contrast-soaked
vaginal packing in situ to highlight unique anatomical detail. The area with
packing was contoured and converted into a 3-dimensional digital image.
The resulting 3-dimensional model was subsequently converted into
a custom applicator with the use of high-resolution rapid prototyping.
Results: A custom vaginal applicator was formed with technical and
practical design considerations for permitting greater lateral dose disper-
sion at vaginal apex compared to the standard uniform cylinder, facilitating
clinical use, and limiting doses to organs at risk. These goals were ach-
ieved using a 2-part construction, optimized channel placement, and
utilization of an alignment dowel. Stereolithographic production was
available within a clinically acceptable timeframe.
Dosimetric results with the custom applicator were compared to
calculated dosimetry for the standard cylinder best suited for the patient’s
anatomy (2.5 cm in diameter). Inverse planning with a prescription point at
5 mm depth resulted in improved dose distribution towards the lateral
aspect of vaginal vault of the custom cylinder relative to the standard
cylinder; 700 cGy versus 328 cGy, respectively. The multi-catheter design
allows for effective treatment of the wide vaginal apex, while simulta-
neously achieving relatively narrow dose distribution in the anterior/
posterior direction, directly translating to rectal and bladder sparing
compared to standard cylinder shapes.
Conclusions: Stereolithographic techniques with high resolution rapid
prototyping are clinically feasible for the provision of patient-specific
intracavitary applicators, and allow for significant improvement in dosi-
metric outcomes of vaginal tissue coverage compared to standard cylinder
applicators.
Author Disclosure: E.M. Wiebe: None. G. Thomas: None. L. Barbera:
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Improving Clinical Target Volume (CTV) Dose Homogeneity and
Normal Tissue Maximum Dose for Endoesophageal High-dose-rate
(HDR) Brachytherapy: One Versus 3 HDR Tube Technique
J.F. Greskovich, M.D. Kolar, A. Wilkinson, and A. Godley; Cleveland
Clinic, Cleveland, OHPurpose/Objective(s):We conducted a dose-volume comparison for CTV
and normal tissues after placement of one or three HDR brachytherapy
tubes in eleven patients undergoing esophageal HDR brachytherapy.
Materials/Methods: A patient with squamous cell carcinoma in situ with
foci suspicious for superficial invasion was treated definitively with HDR
brachytherapy, 30Gy in 6 applications, delivered once per week. The first
fraction used a single 1.5 meter brachytherapy tube; subsequent fractions
used 3 tubes. Radiopaque clips were placed 2 cm proximal and 2 cm distal
to endoscopic tumor. The patient underwent CT-based treatment planning.
The CTV was defined as a 2 mm thickness of the mucosal wall between
the distal and proximal radiopaque clips. We evaluated the dose-volume
relationships for CTV and normal tissues for the one versus three catheter
techniques, each planned with V100 of 90%. The maximum dose to the
normal tissues was defined as the dose received by a volume of 0.04 cc.
Dice’s Coefficient (DC) was calculated in eleven additional patients who
underwent 43 total HDR applications (36 three-tube technique, 7 one-
tube). DC is calculated as overlap volume of the prescription isodose line
(PIDL) with the CTV (i.e., CTV V100) divided by average volume of
PIDL and CTV, with DC Z 1 representing perfect agreement. The
advantage of DC over conformity index is that it includes under- as well as
over-lap information.
Results: TheV100, V150, V200, V300 were 90.0%, 73.5%, 62.3%, 46.0%
vs. 90.2%, 66.7%, 41.5%, 17.7%, for the one and three catheter place-
ments, respectively. For the three catheter technique, the implant volume
was 50% smaller (V100: 42.7cc vs. 83.8cc; V150: 22.2cc vs. 42.9cc;
V200: 13.1cc vs. 26.0cc; V300: 5.6cc vs. 12.3cc). With respect to the
normal tissues, the heart (6.0Gy vs. 11.2Gy), right lung (4.3Gy vs.
12.0Gy), right proximal bronchial tree (6.2Gy vs. 13.1Gy), trachea (5.8Gy
vs. 7.3Gy), and vertebral body (6.5Gy vs. 13.1Gy) received much lower
doses per fraction using the three catheter technique vs. the single catheter
technique. Comparing 11 patients, using 3 catheters, the DC significantly
improves to 0.38 from 0.30 vs. 1 catheter, P<0.058. In this case,
comparing a tubular CTV, to a cylindrical PIDL, the best DC achievable is
0.56 on average.
Conclusions: The dose homogeneity and DC was improved using 3 bra-
chytherapy catheters vs. 1 catheter. The 3 catheter technique led to 50%
smaller implant volumes receiving high fractional dose, lower maximum
normal tissue doses, and more conformal dose. This improvement in
decreasing the volume of the “hot spots” both to the CTVand normal tissues
may lead to an improved therapeutic ratio with lower rates of complications.
Author Disclosure: J.F. Greskovich: None. M.D. Kolar: None. A. Wil-
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Optimization of Monte Carlo Code for Clinical Simulation of
Electron Beams
P. Guerra Gutierrez,1 J.M. Udias,2 E. Herranz,2 M. Valdivieso,3 J. Calama,4
C. Illana,3 M.J. Ledesma-Carbayo,1,5 and A. Santos1,5; 1Universidad
Polite´cnica de Madrid, Madrid, Spain, 2Universidad Complutense de
Madrid, Madrid, Spain, 3GMV, Madrid, Spain, 4Clinica La Luz, Madrid,
Spain, 5CIBER-BBN, Madrid, Spain
Purpose/Objective(s): The aim of this work is to optimize a Monte Carlo
(MC) kernel for electron radiation therapy (IOERT) compatible with
intraoperative usage and to integrate it within an existing IOERT dedicated
treatment planning system (TPS).
Materials/Methods: The MC method is known to accurately calculate
dose distributions but computational may limit their clinical use. In this
work the existing Dose Planning Method is recoded in C++ and optimized
for parallel execution in Windows based multi-core platforms, with no
change in the physics modeling. Parallelization at the particle level with
Windows native threads is straightforward. Read only data structures are
shared among threads, to reduce memory footprint and increase cache hits,
while dose volumes are per thread to avoid access contention. Particles are
created on-line, based on tabulated phase spaces. These have been
computed for energies between 6 and 20 MeVs and applicator diameters
between 5 and 9 cm using a maximum likelihood iterative algorithm that
Volume 84  Number 3S  Supplement 2012 Poster Viewing Abstracts S871estimates particle distributions, based on water measurements. The actual
clinical setup for IOERT is considered to evaluate the kernel. Phase space
characterization and dose distributions correspond with experimental
measurements from a commercial linear accelerator.
Results: Execution time to meet a target uncertainty grows with energy
and applicator section. Performance improvements of MC codes by
threading into multiple cores strongly depend on the memory architecture.
Simulations for 1x1x1 mm3 water phantoms were run in an Intel i7-870
with every combination of applicator diameter and energy, with an
excellent agreement in the mean energy and build up regions. Computation
time for a 4% uncertainty ranges from 1’ (5 cm/6MeVs) to 12’ (9 cm/
20MeVs). Dose computation in the breast, where radiation penetration is
limited by protection, is executed in around a minute.
Conclusions: The implemented code allows for clinically relevant dose
computations within a reasonable time. The tool narrows the gap between
external and intraoperative radiation therapy, enabling radiation oncolo-
gists to plan treatment for the possible scenarios he may face.
Acknowledgment: This work is supported by projects CENIT-AMIT, IPT-
300000-2010-3, TEC2010-21619-C04-3 and P2009/DPI-1802.
Author Disclosure: P. Guerra Gutierrez: None. J.M. Udias: None. E.
Herranz: None. M. Valdivieso: None. J. Calama: None. C. Illana: None.




Corr. Coef. p-value (FRV)
Perfusion (PBF)
Corr. Coef. p-value (PBF)
P1 0.87 0.005 0.93 0.0009
P2 0.93 0.0009 0.96 0.0002
P3 0.94 0.0006 0.93 0.0008
P4 0.95 0.0002 0.95 0.00023731
Study of the Radiation Dose Enhancement at the Gold-Tissue
Interface in Gold Nanoparticle-aided Radiation Therapy With
Microdosimetry Technique
E. Parsai, N. Paudel, and D. Shvydka; University of Toledo Health Science
Campus, Toledo, OH
Purpose/Objective(s): Nanoparticles of high atomic number materials,
such as gold nanoparticles (AuNP), have shown a lot of promise in their
exploitation for local tumor dose enhancement in radiation therapy,
especially in the low energy range relevant to brachytherapy applications.
Most researchers study the dose enhancement effect through either Monte
Carlo (MC) simulations, or experimental approaches involving biological
systems, where achievable physical dose enhancements are difficult to
quantify. The dosimetry in such a system is not trivial, as the dose
enhancement rapidly falls-of over a very short distance from the gold-
tissue interface. The purpose of this study is to establish a micro-dosimetry
technique for the experimental verification of dose enhancement in the
neighborhood of gold-tissue interface.
Materials/Methods: The spatial distribution of the dose enhancement near
the gold-tissue interface is modeled with Monte Carlo (MC) package
MCNP5 in a 1-dimensional approach. Thin gold foil was placed in a tissue
phantom comprising of ICRU-4 components. The model replicates the
experiment, where the dose enhancement due to gold foils having thick-
nesses of 1, 10, and 100mm and areas of 12.5x25mm2 are placed at a short
distance from clinical HDR brachytherapy (Ir-192) source. The measure-
ments are carried out with a thin-film CdTe-based photodetector, having
thickness < 10mm, and operating in a photovoltaic mode. The small
thickness of the detector ensures high spatial resolution of the measure-
ment at progressively increasing distances from the foil.
Results: OurMC simulation results indicate that for Ir-192 energy spectrum
the dose enhancement region extends over the distance ofw1 mm from the
foil, where the magnitude of enhancement changes from several hundred to
just a few percent. Our experimental results for gold foils of several thick-
nesses are in close agreement with the modeled data, confirming the feasi-
bility of the explored micro-dosimetry approach. We also investigated an
influence of the photodetector substrate on the measured data.
Conclusion:We have successfully established a micro-dosimetry technique
for experimental verification of the dose enhancement near gold-tissue
interface, applicable to the AuNP-aided radiation therapy treatments. Our
approach will pave a way for direct assessment of the dose in experiments
on biological models, shedding some light on apparent discrepancy
between the physical dose enhancement and resulting biological effect.
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Validation of High-Resolution Multimodality Imaging of
Pretreatment Lung Function in Pulmonary Neoplasms
T. Diwanji,1 S. Pokharel,2 S. Feigenberg,1 W. D’Souza,1 and N. Mistry1;
1University of Maryland School of Medicine, Baltimore, MD, 2Morgan
State University, Baltimore, MD
Purpose/Objective(s): There is a growing interest in using functional
information for treatment planning. However, existing clinical techniques
are limited in value due to their low spatial resolution. Here, we propose
the use of multi-modality imaging of lung ventilation and lung perfusion at
high spatial resolution using 4D-CT and 4D-Dynamic Contrast Enhanced
MRI (DCE-MRI), respectively. Furthermore, we validate these techniques
against the current clinical standards for evaluation of lung function, i.e.,
Scintigraphy Ventilation and Perfusion (VQ scans) and Pulmonary Func-
tion Tests (PFTs).
Materials/Methods: VQ scans, 4D-CT, and DCE-MRIs, were acquired in
4 patients prior to radiation therapy. PFTs were acquired in 3 out of the 4
patients. 4D-CT images were used to create 3D fractional regional venti-
lation (FRV) maps by applying a “mass correction” and subtracting the
spatially matched end-exhale and end-inhale images. DCE-MRI images
were acquired using a fast-volumetric scan that tracks a bolus of a gado-
linium based contrast agent to extract voxel-by-voxel estimates pulmonary
blood flow (PBF). Standard clinical protocols were utilized for the
acquisition and analysis of scintigraphy VQ data. Manual contouring of the
lung was performed to eliminate the heart and large blood vessels from the
analysis. FRV and PBF maps were collapsed in the anterior-posterior
dimension to create coronal 2D projection images consistent with the
scintigraphy VQ scan images. The projections were divided into 6 sections
of equal height analogous to the analysis performed on VQ scans and
statistically compared using the Kendall’s tau rank correlation.
Results: Kendall’s tau estimate for correlation between the FRV/PBF and
V/Q measurements are reported in Table. Mean functional residual
capacities (FRC) from the PFTs (N Z 3) versus calculated FRCs from
FRV maps were 2.7 +/- 0.6 L and 2.4 +/- 0.7 L, respectively, and the
null hypothesis could not be rejected (p Z 0.61), implying statistical
similarity between multi-modality techniques and “gold-standard”.
Conclusion: There was a strong correlation between scintigraphy VQ and
multimodality measurements of ventilation and perfusion. The similarity
between the calculated and measured FRCs further validates the utility of
4D-CT to evaluate ventilation. Furthermore, the significant increase in
spatial resolution compared to the clinical “gold-standard” highlights the
utility of high-resolution multi-modality functional lung imaging.Author Disclosure: T. Diwanji: None. S. Pokharel: None. S. Feigenberg:
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A Comparison of Lung SBRT Using Volumetric Modulated Arc
Therapy With Static Field IMRT
G. Kim, J. Uhl, A. Sandhu, and T. Pawlicki; UCSD Medical Center, La
Jolla, CA
Purpose/Objective(s): Volumetric modulated arc therapy allows for fast
delivery of stereotactic body radiation therapy (SBRT) delivery in lung
cancer treatment. At our institution, SBRT lung patients are planned using
either volumetric modulated arc therapy (VMAT) or Static Field IMRT
